Economic evaluation analysis comprises a set of tools that are used to assess alternative health tech-nologies, including assistive technologies. Health technology assessment is a set of concepts that are used to evaluate technologies and to make policy recommendations. This article presents an exposi-tion of each of these areas: the tools that are used to conduct an economic evaluation, how these tools fit in to the larger policy-related analysis of health technology assessment, and how these tools can be used in the assistive technology field. Because these technologies are designed for persons with diverse disabilities, a multitude of low to high technology de-vices exist (Cook & Hussey, 2002). Developed for an extensive range of app...
Early decision-making process about the development of a new product is essential for any company in...
Finding the equilibrium between raising demand for healthcare services and increasing cost containme...
Assistive technology makes up a substantial portion of the direct cost of multiple sclerosis (MS). E...
The paper presents a scoping review of existing economic evaluations of assistive technology (AT). T...
Economic evaluation is a useful and increasingly popular tool that helps policy makers and health pr...
Assistive Technologies (AT) is a rapid growth area to enhance participation, freedom from personal s...
Purpose: This paper identifies key methodological issues for economic analyses of costs and effectiv...
Government funded assistive technology (AT) supply schemes in Australia operate at less than optimal...
The aging of the population structure and the increase in acquired disabilities lead to a greater ne...
https://scholarworks.moreheadstate.edu/student_scholarship_posters/1074/thumbnail.jp
Health economics is the study of allocating scarce goods within a healthcare market. Due to constrai...
The economic evaluation which supports Health Technology Assessment (HTA) should inform policy maker...
Disabled people often do not use the equipment supplied to them. Past work indicates that there are ...
Purpose: It is estimated that only 5–15% of people in low and middle income countries (LMICs) who ne...
The aim of this article is to show the general possibility of application of chosen economic evalua...
Early decision-making process about the development of a new product is essential for any company in...
Finding the equilibrium between raising demand for healthcare services and increasing cost containme...
Assistive technology makes up a substantial portion of the direct cost of multiple sclerosis (MS). E...
The paper presents a scoping review of existing economic evaluations of assistive technology (AT). T...
Economic evaluation is a useful and increasingly popular tool that helps policy makers and health pr...
Assistive Technologies (AT) is a rapid growth area to enhance participation, freedom from personal s...
Purpose: This paper identifies key methodological issues for economic analyses of costs and effectiv...
Government funded assistive technology (AT) supply schemes in Australia operate at less than optimal...
The aging of the population structure and the increase in acquired disabilities lead to a greater ne...
https://scholarworks.moreheadstate.edu/student_scholarship_posters/1074/thumbnail.jp
Health economics is the study of allocating scarce goods within a healthcare market. Due to constrai...
The economic evaluation which supports Health Technology Assessment (HTA) should inform policy maker...
Disabled people often do not use the equipment supplied to them. Past work indicates that there are ...
Purpose: It is estimated that only 5–15% of people in low and middle income countries (LMICs) who ne...
The aim of this article is to show the general possibility of application of chosen economic evalua...
Early decision-making process about the development of a new product is essential for any company in...
Finding the equilibrium between raising demand for healthcare services and increasing cost containme...
Assistive technology makes up a substantial portion of the direct cost of multiple sclerosis (MS). E...